Single-cell transcriptomics has revealed heterogeneity in IDO1/TDO2 expression across tumor and stromal compartments, demonstrating that localized tryptophan metabolism can differentially shape immune niches within the same tumor. The gene discussed is TDO2; the disease is neoplasm.